AbCellera Biologics Inc. (ABCL)
NASDAQ: ABCL · Real-Time Price · USD
6.17
+0.40 (6.93%)
At close: Oct 8, 2025, 4:00 PM EDT
6.35
+0.18 (2.92%)
After-hours: Oct 8, 2025, 6:51 PM EDT
AbCellera Biologics Market Cap
AbCellera Biologics has a market cap or net worth of $1.84 billion as of October 8, 2025. Its market cap has increased by 141.59% in one year.
Market Cap
1.84B
Enterprise Value
1.43B
1-Year Change
141.59%
Ranking
Category
Stock Price
$6.17
Market Cap Chart
Since the IPO on December 11, 2020, AbCellera Biologics's market cap has decreased from $15.66B to $1.84B, a decrease of -88.23%. That is a compound annual growth rate of -35.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 1.72B | 99.24% |
| Dec 31, 2024 | 865.42M | -47.77% |
| Dec 29, 2023 | 1.66B | -42.83% |
| Dec 30, 2022 | 2.90B | -28.02% |
| Dec 31, 2021 | 4.03B | -62.83% |
| Dec 31, 2020 | 10.83B | -30.85% |
| Dec 11, 2020 | 15.66B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 753.98B |
| Johnson & Johnson | 454.31B |
| AbbVie | 413.22B |
| UnitedHealth Group | 326.22B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 234.25B |